| Literature DB >> 16988005 |
Geoffrey W Stone1, Suzanne Barzee, Victoria Snarsky, Celsa A Spina, Jeffrey D Lifson, Vinod Kumar Bhaskara Pillai, Rama Rao Amara, François Villinger, Richard S Kornbluth.
Abstract
CD40 ligand (CD40L) and GITR ligand (glucocorticoid-induced tumor necrosis factor receptor-related protein ligand [GITRL]) are tumor necrosis factor superfamily molecules that can be used as vaccine adjuvants. In a previous human immunodeficiency virus (HIV) DNA vaccine study in mice, we found that plasmids expressing multimeric soluble forms of trimeric CD40L (i.e., many trimers) were stronger activators of CD8(+) T-cell responses than were single-trimer soluble forms or the natural membrane-bound molecule. This report describes similar multimeric soluble molecules that were constructed for studies in macaques. Both two-trimer and four-trimer forms of macaque CD40L were active in B-cell proliferation assays using macaque and human cells. With human cells, four-trimer macaque GITRL costimulated CD4(+) T-cell proliferation and abrogated the immunosuppressive effects of CD4(+) CD25(+) regulatory T cells on a mixed leukocyte reaction. These molecular adjuvants provide new tools for vaccine development in the simian immunodeficiency virus system and other macaque models.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16988005 PMCID: PMC1656546 DOI: 10.1128/CVI.00198-06
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X